Recombinant follikelstimulerend hormoon (FSH); hoe lang nog 1grootmoeders' voor moeders?

Nederlands Tijdschrift voor Geneeskunde

Volumn 140, Issue 40, 1996, Pages 1976-1978

  Merkus, J M W M ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

CHORIONIC GONADOTROPIN; FOLLITROPIN; GONADOTROPIN; LUTEINIZING HORMONE;

DRUG USE; FEMALE; FERTILIZATION IN VITRO; HUMAN; OVARY HYPERSTIMULATION; OVULATION INDUCTION; PREGNANCY; RECOMBINANT DNA TECHNOLOGY; SHORT SURVEY;

FEMALE; FERTILIZATION IN VITRO; FOLLICLE STIMULATING HORMONE; FOLLICLE STIMULATING HORMONE, BETA SUBUNIT; HUMANS; OVARY; RECOMBINANT PROTEINS;

EID: 0029845771     PISSN: 00282162     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (6)

1. School BCh, Vemer HM, Fauser BCJM. Gonadotrofinen en inductie van (super)ovulatie. Ned Tijdschr Geneeskd 1992:136:217-20.
2. Zondeck B. Aschheim S. Das Hormon des Hypofysenvorderlappens. Klin Wochenschr 1927:6:248.
3. Hamblen EC, Davis CD. Treatment of hypo-ovarianism by the sequential and cyclic administration of equine and chorionic gonadotropins. Am J Obstet Gynaecol 1945;50:137-9.
4. Gemzell CA, Diczfalusy E, Tillinger KG. Clinical effect of human pituitary follicle stimulating hormone. J Clin Endocrinol Metab i958;18:1333-6.
5. Lunenfeld B. Treatment of anovulation by human gondotropins. J Int Pert Gynaecol Obstet 1962;1:153-5.
6. Out HJ, Mannaerts BMJL, Driessen SGAJ, Coelingh Bennink HJT. A prospective, randomized, assessor-blind, multicentre study comparing recombinant and urinary follicle stimulating hormone (Puregon versus Metrodin) in in-vitro fertilization. Hum Reprod 1995:10: 2534-40.